• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新评估肺动脉高压分类:采用射血分数保留的心力衰竭标准而非肺动脉楔压

Reassessing Pulmonary Hypertension Classification: Utilizing Criteria for Heart Failure with Preserved Ejection Fraction Instead of Pulmonary Arterial Wedge Pressure.

作者信息

Park Da-Hee, Fuge Jan, Kamp Jan Christopher, Harrigfeld Britta, Berliner Dominik, Hoeper Marius M, Olsson Karen M

机构信息

Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), 30625 Hannover, Germany.

出版信息

J Clin Med. 2024 Dec 13;13(24):7582. doi: 10.3390/jcm13247582.

DOI:10.3390/jcm13247582
PMID:39768504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11728240/
Abstract

: The current classification of pulmonary hypertension (PH) distinguishes between pre-capillary (PAWP ≤ 15 mmHg) and post-capillary (PAWP > 15 mmHg) forms, with left heart disease, especially heart failure with preserved ejection fraction (HFpEF), being a common cause of PH. We investigated the suitability of an HFpEF diagnosis instead of PAWP in diagnosing PH associated with HFpEF. : In a retrospective, single-center analysis, we reviewed diagnoses from our database, focusing on patients initially diagnosed with idiopathic pulmonary arterial hypertension (IPAH) or PH associated with HFpEF (PH-HFpEF) based on their PAWP. These patients were reclassified, distinguishing between HFpEF and non-HFpEF cases. Patients with PH-HFpEF were further stratified by PAWP (≤15 mmHg or >15 mmHg). : The study included 350 patients: 214 (61.1%) with PAWP ≤ 15 mmHg and 136 (38.9%) with PAWP > 15 mmHg. Replacing the PAWP criterion with the HFpEF criterion resulted in the reclassification of 121 of 350 (34.6%) patients (115 of 214 [53.7%] from IPAH to PH-HFpEF and 6 of 136 [4.4%] from PH-HFpEF to IPAH). The final disposition was IPAH (n = 105, 30%), PH-HFpEF with PAWP ≤ 15 mmHg (n = 115, 32.9%), and PH-HFpEF with PAWP > 15 mmHg (n = 130, 37.1%). Characteristics such as age distribution, functional impairment, co-morbidities, echocardiographic indices of HFpEF, pulmonary vascular resistance, response to PH medications, and unadjusted survival were comparable between the two HFpEF cohorts but differed substantially from those with IPAH. : PH-HFpEF patients with PAWP ≤ 15 mmHg resemble those with PAWP > 15 mmHg but differ from IPAH cases. Incorporating non-invasive HFpEF criteria could refine PH diagnostic classification.

摘要

目前肺动脉高压(PH)的分类区分了毛细血管前(肺动脉楔压≤15mmHg)和毛细血管后(肺动脉楔压>15mmHg)形式,左心疾病,尤其是射血分数保留的心力衰竭(HFpEF),是PH的常见病因。我们研究了用HFpEF诊断取代肺动脉楔压在诊断与HFpEF相关的PH中的适用性。

在一项回顾性单中心分析中,我们审查了数据库中的诊断结果,重点关注最初根据肺动脉楔压诊断为特发性肺动脉高压(IPAH)或与HFpEF相关的PH(PH-HFpEF)的患者。这些患者被重新分类,区分HFpEF和非HFpEF病例。PH-HFpEF患者进一步按肺动脉楔压分层(≤15mmHg或>15mmHg)。

该研究纳入了350例患者:214例(61.1%)肺动脉楔压≤15mmHg,136例(38.9%)肺动脉楔压>15mmHg。用HFpEF标准取代肺动脉楔压标准导致350例患者中的121例(34.6%)重新分类(214例中的115例[53.7%]从IPAH重新分类为PH-HFpEF,136例中的6例[4.4%]从PH-HFpEF重新分类为IPAH)。最终分类为IPAH(n = 105,30%)、肺动脉楔压≤15mmHg的PH-HFpEF(n = 115,32.9%)和肺动脉楔压>15mmHg的PH-HFpEF(n = 130,37.1%)。两个HFpEF队列之间在年龄分布、功能损害、合并症、HFpEF的超声心动图指标、肺血管阻力、对PH药物的反应和未调整的生存率等特征方面具有可比性,但与IPAH患者有很大差异。

肺动脉楔压≤15mmHg的PH-HFpEF患者与肺动脉楔压>15mmHg的患者相似,但与IPAH病例不同。纳入非侵入性HFpEF标准可以完善PH诊断分类。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fc/11728240/7f304783e05a/jcm-13-07582-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fc/11728240/0b9f160354e1/jcm-13-07582-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fc/11728240/e5dcfbec0f51/jcm-13-07582-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fc/11728240/7bc3b91477fb/jcm-13-07582-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fc/11728240/7f304783e05a/jcm-13-07582-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fc/11728240/0b9f160354e1/jcm-13-07582-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fc/11728240/e5dcfbec0f51/jcm-13-07582-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fc/11728240/7bc3b91477fb/jcm-13-07582-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fc/11728240/7f304783e05a/jcm-13-07582-g004.jpg

相似文献

1
Reassessing Pulmonary Hypertension Classification: Utilizing Criteria for Heart Failure with Preserved Ejection Fraction Instead of Pulmonary Arterial Wedge Pressure.重新评估肺动脉高压分类:采用射血分数保留的心力衰竭标准而非肺动脉楔压
J Clin Med. 2024 Dec 13;13(24):7582. doi: 10.3390/jcm13247582.
2
Capillary pCO2 helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction.毛细血管二氧化碳分压有助于鉴别特发性肺动脉高压与射血分数保留的心力衰竭所致肺动脉高压。
Respir Res. 2015 Mar 10;16(1):34. doi: 10.1186/s12931-015-0194-6.
3
Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.毛细血管前、混合性和毛细血管后肺动脉高压:一种病理生理连续统。
J Am Coll Cardiol. 2016 Jul 26;68(4):368-78. doi: 10.1016/j.jacc.2016.05.047.
4
Definitions and diagnosis of pulmonary hypertension.肺动脉高压的定义和诊断。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D42-50. doi: 10.1016/j.jacc.2013.10.032.
5
Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements.利用同时进行的超声心动图和有创测量评估射血分数保留的心力衰竭患者的左心室和肺循环压力:一项研究
Eur J Heart Fail. 2017 Dec;19(12):1651-1660. doi: 10.1002/ejhf.957. Epub 2017 Oct 6.
6
CTA-derived left to right atrial size ratio distinguishes between pulmonary hypertension due to heart failure and idiopathic pulmonary arterial hypertension.CTA得出的左心房与右心房大小比值可区分由心力衰竭引起的肺动脉高压和特发性肺动脉高压。
Int J Cardiol. 2016 Nov 15;223:723-728. doi: 10.1016/j.ijcard.2016.08.314. Epub 2016 Aug 22.
7
Atrial fibrillation modifies the association between pulmonary artery wedge pressure and left ventricular end-diastolic pressure.心房颤动改变了肺动脉楔压与左心室舒张末期压之间的关联。
Eur J Heart Fail. 2017 Nov;19(11):1483-1490. doi: 10.1002/ejhf.959. Epub 2017 Sep 25.
8
Exercise-induced changes in pulmonary artery wedge pressure in adults post-Fontan versus heart failure with preserved ejection fraction and non-cardiac dyspnoea.成人法乐四联症根治术后与射血分数保留心力衰竭及非心源性呼吸困难时肺动脉楔压在运动诱导下的变化。
Eur J Heart Fail. 2023 Jan;25(1):17-25. doi: 10.1002/ejhf.2706. Epub 2022 Oct 23.
9
Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.射血分数降低或保留且伴有肺动脉高压的心力衰竭患者的肺血流动力学:异同点
Am Heart J. 2017 Oct;192:120-127. doi: 10.1016/j.ahj.2017.06.006. Epub 2017 Jun 21.
10
Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure Predicts Outcome in Heart Failure With Preserved Ejection Fraction.节段性室壁压力而非左心室舒张末期压力预测射血分数保留心力衰竭的预后。
JACC Heart Fail. 2017 Nov;5(11):795-801. doi: 10.1016/j.jchf.2017.08.005. Epub 2017 Oct 11.

本文引用的文献

1
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity.替尔泊肽用于射血分数保留的心力衰竭合并肥胖症
N Engl J Med. 2025 Jan 30;392(5):427-437. doi: 10.1056/NEJMoa2410027. Epub 2024 Nov 16.
2
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.非奈利酮治疗射血分数轻度降低或保留的心力衰竭。
N Engl J Med. 2024 Oct 24;391(16):1475-1485. doi: 10.1056/NEJMoa2407107. Epub 2024 Sep 1.
3
Pulmonary hypertension associated with left heart disease.与左心疾病相关的肺动脉高压。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01344-2024. Print 2024 Oct.
4
Misclassification of Pulmonary Hypertension With Current Hemodynamic Criteria.根据当前血流动力学标准对肺动脉高压的错误分类。
Chest. 2025 Jan;167(1):241-244. doi: 10.1016/j.chest.2024.05.053. Epub 2024 Aug 27.
5
Heart failure with preserved ejection fraction: everything the clinician needs to know.射血分数保留的心力衰竭:临床医生需要了解的一切。
Lancet. 2024 Mar 16;403(10431):1083-1092. doi: 10.1016/S0140-6736(23)02756-3. Epub 2024 Feb 14.
6
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.《2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》2023年聚焦更新
Eur Heart J. 2023 Oct 1;44(37):3627-3639. doi: 10.1093/eurheartj/ehad195.
7
Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction.运动诱发的射血分数保留心力衰竭中的左心房高血压。
JACC Heart Fail. 2023 Aug;11(8 Pt 2):1103-1117. doi: 10.1016/j.jchf.2023.01.030. Epub 2023 Mar 20.
8
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.索他洛尔治疗肺动脉高压的3期试验
N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6.
9
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.肺动脉高压合并症患者的风险分层及对治疗的反应:一项COMPERA分析
J Heart Lung Transplant. 2023 Jan;42(1):102-114. doi: 10.1016/j.healun.2022.10.003. Epub 2022 Oct 13.
10
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00879-2022. Print 2023 Jan.